Loss of carbamoyl phosphate synthetase I in small-intestinal adenocarcinoma

American Journal of Clinical Pathology

Volumn 132, Issue 6, 2009, Pages 877-882

  Cardona, Diana M ^a   Zhang, Xiaokui ^a   Liu, Chen ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Carbamoyl phosphate synthetase I; CSP1; Hep Par 1; Small intestinal adenocarcinoma; Small intestinal adenoma

Indexed keywords

ANTIBODY; CARBAMOYL PHOSPHATE SYNTHASE; HEP PAR 1 ANTIBODY; UNCLASSIFIED DRUG;

ADENOMA; ARTICLE; CONTROLLED STUDY; GASTROINTESTINAL CARCINOMA; GENE EXPRESSION; GENE LOSS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTESTINE CELL; PRIORITY JOURNAL; SMALL INTESTINE ADENOCARCINOMA; SMALL INTESTINE ADENOMA; STATISTICAL SIGNIFICANCE; WESTERN BLOTTING;

ADENOCARCINOMA; ADENOMA; CARBAMOYL-PHOSPHATE SYNTHASE (AMMONIA); DUODENAL NEOPLASMS; DUODENITIS; DUODENUM; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; NEOPLASM INVASIVENESS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 72949095450     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/AJCP74XGRFWTFLJU     Document Type: Article

References (21)

1. Van Beers EH, Rings E, Posthuma G, et al. Intestinal carbamoyl phosphate synthase I in human and rat: expression during development shows species differences and mosaic expression in duodenum of both species. J Histochem Cytochem. 1998;46:231-240.
2. Wu G. Urea synthesis in enterocytes of developing pigs. Biochem J. 1995;312:717-723.
3. Wu G, Knabe DA, Flynn NE. Synthesis of citrulline from glutamine in pig enterocytes. Biochem J. 1994;299(pt 1):115-121.
4. Ryall JC, Quantz MA, Shore GC. Rat liver and intestinal mucosa differ in the developmental pattern and hormonal regulation of carbamoyl-phosphate synthetase I and ornithine carbamoyl transferase gene expression. Eur J Biochem. 1986;156:453-458.
5. Butler BL, Dong H, Cardona D, et al. The antigen for Hep Par 1 antibody is the urea cycle enzyme carbamoyl phosphate synthetase 1. Lab Invest. 2008;88:78-88.
6. Haselkorn T, Whittemore AS, Lilienfeld DE. Incidence of small bowel cancer in the United States and worldwide: geographic, temporal and racial differences. Cancer Causes Control. 2005;16:781-787.
7. Wright NH, Howe JR, Rossini FP, et al. Carcinoma of the small intestine. In: Hamilton SR, Aaltonen LA, eds. Pathology and Genetics of Tumours of the Digestive System. Lyon, France: IARC Press; 2000:71-74. World Health Organization Classification of Tumours.
8. Brosens LA, Keller JJ, Offerhaus GJ, et al. Prevention and management of duodenal polyps in familial adenomatous polyposis. Gut. 2005;54:1034-1043.
9. Stemmermann GN, Goodman MT, Normura AMY. Adenocarcinoma of the proximal small intestine. Cancer. 1992;70:2766-2771.
10. Vasen HF, Wijnen JT, Menko FH, et al. Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology. 1996;110:1020-1027.
11. Wright DH. The major complication of celiac disease. Baillieres Clin Gastroenterol. 1995;9:351-369.
12. Sellner F. Investigations on the significance of the adenomacarcinoma sequence in the small bowel. Cancer. 1990;66:702-715.
13. Davis PK, Wu G. Compartmentation and kinetics of urea cycle enzymes in porcine enterocytes. Comp Biochem Physiol B Biochem Mol Biol. 1998;119:527-537.
14. Moonen R, Paulussen A, Souren N, et al. Carbamoyl phosphate synthetase polymorphisms as a risk factor for necrotizing enterocolitis. Pediatr Res. 2007;62:188-190.
15. Amin HJ, Zamora SA, McMillan DD, et al. Arginine supplementation prevents necrotizing enterocolitis in the premature infant. J Pediatr. 2000;131:226-232.
16. Chu PG, Jiang Z, Weiss LM. Hepatocyte antigen as a marker of intestinal metaplasia. Am J Surg Pathol. 2003;27:952-959.
17. Zhang J, Parwani AV, Ali SZ. Hepatocyte paraffin 1 immunoexpression in esophageal brush samples: a sensitive marker for Barrett esophagus with intestinal metaplasia. Cancer. 2005;105:304-309.
18. Chue PG, Weiss LM. Immunohistochemical characterization of signet-ring cell carcinomas of the stomach, breast, and colon. Am J Clin Pathol. 2004;121:884-892.
19. Fan Z, van de Rijn M, Montgomery K, et al. Hep par1 antibody stain for the differential diagnosis of hepatocellular carcinoma: 676 tumors tested using tissue microarrays and conventional tissue sections. Mod Pathol. 2003;16:137-144.
20. Adler DG, Qureshi W, Davilla R, et al. The role of endoscopy in ampullary and duodenal adenomas. Gastrointest Endosc. 2006;64:849-854.
21. Tran TC, Vitale GC. Ampullary tumors: endoscopic versus operative management. Surg Innov. 2004;11:255-263.